EP 0831798 A1 19980401 - USE OF SELEGILINE TO TREAT HEARING LOSS IN MAMMALS
Title (en)
USE OF SELEGILINE TO TREAT HEARING LOSS IN MAMMALS
Title (de)
VERWENDUNG VON SELEGILIN ZUR BEHANDLUNG VON GEHÖRVERLUST BEI SAUGE TIEREN
Title (fr)
UTILISATION DE SELEGILINE DANS LE TRAITEMENT DE PERTES D'AUDITION CHEZ DES MAMMIFERES
Publication
Application
Priority
- US 9608642 W 19960603
- US 47518695 A 19950607
Abstract (en)
[origin: US5561163A] Selegiline and pharmaceutically acceptable analog forms thereof are used as treatments for hearing loss in mammals, especially dogs.
IPC 1-7
IPC 8 full level
A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61P 9/00 (2006.01); A61P 27/16 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP US)
A61K 31/135 (2013.01 - EP US); A61K 31/137 (2013.01 - EP US); A61P 9/00 (2017.12 - EP); A61P 27/16 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 9640094A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 5561163 A 19961001; AT E234614 T1 20030415; AU 5977296 A 19961230; AU 693704 B2 19980702; CA 2221255 A1 19961219; CA 2221255 C 20051108; DE 69626816 D1 20030424; DE 69626816 T2 20040205; EP 0831798 A1 19980401; EP 0831798 B1 20030319; ES 2194104 T3 20031116; JP 3094305 B2 20001003; JP H10510843 A 19981020; WO 9640094 A1 19961219
DOCDB simple family (application)
US 47518695 A 19950607; AT 96917093 T 19960603; AU 5977296 A 19960603; CA 2221255 A 19960603; DE 69626816 T 19960603; EP 96917093 A 19960603; ES 96917093 T 19960603; JP 50117497 A 19960603; US 9608642 W 19960603